EFFECTS OF BIOFLAVONOIDS ON HEPATIC P450 ACTIVITIES

被引:125
作者
OBERMEIER, MT [1 ]
WHITE, RE [1 ]
YANG, CS [1 ]
机构
[1] RUTGERS STATE UNIV,COLL PHARM,DEPT CHEM BIOL & PHARMACOGNOSY,CANC RES LAB,PISCATAWAY,NJ 08855
关键词
D O I
10.3109/00498259509061876
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The effects of tangeretin, green tea flavonoids, and other flavonoids on 7-ethoxyresorufin-O-deethplase (EROD; 450 1A), 7-pentoxyresorufin-O-dealkylase (PROD; P450 2B), P-nitrophenol hydroxylase (PNPH, P450 2E1), and erythromycin-N-demethylase (ERDM; P450 3A) were examined in induced rat liver microsomes. EROD, PNPH, ERDM, and nifedipine oxidase (NIFO; P450 3A4) were examined in human liver microsomes. 2. All flavonoids tested inhibited EROD activity at higher concentrations in liver microsomes. Flavone and tangeretin were potent inhibitors of EROD, with IC50's of 0.7 and 0.8 mu M respectively in rat liver microsomes and 0.15 and 16 mu M respectively in human liver microsomes. The green tea flavonoid (-)-epicatechin-3-gallate (EGG) was the most potent inhibitor of EROD in human liver microsomes (IC50 = 75 mu M). The effect of the green tea flavonoids on EROD was complex; in addition to inhibition at high concentrations of flavonoid, moderate activation was seen at lower concentrations. 3. 450 2B-, 2E1- and 3A-dependent activities in rat and human liver microsomes were only moderately inhibited by any of the flavonoids tested, and, in general, ECG was the most potent inhibitor for these activities with IC50's ranging from 75 to 300 mu M. 4. Tangeretin inhibited EROD activity (P450 1A2) in human liver microsomes in a competitive manner with a K-i = 68 nM. Tangeretin inhibited NIFO activity (P450 3A4) inhuman liver microsomes in an uncompetitive manner with K-i = 72 mu M.
引用
收藏
页码:575 / 584
页数:10
相关论文
共 28 条
[1]  
Beyeler S., Testa B., Perrissoud D., The effect of ciandanol on rat hepatic monooxygenase activities, Arzneim.-Forsch./Drug Research, 33, pp. 564-567, (1983)
[2]  
Buening M.K., Chang R.L., Huang M.-T., Fortner J.G., Wood A.W., Conney A.H., Activation and inhibition of benzo(a)pyrene and aflatoxin B<sub>1</sub> metabolism in human liver microsomes by naturally occurring flavonoids, Cancer Research, 41, pp. 67-72, (1981)
[3]  
Canivenc-Lavier M.-C., Brunold C., Siess M.-H., Suschetet M., Evidence for tangeretin-O-demethylation by rat and human liver microsomes, Xenobiotica, 23, pp. 259-266, (1993)
[4]  
Das M., Mukhtar H., Bik D.P., Bickers D.R., Inhibition of epidermal xenobiotic metabolism in SENCAR mice by naturally occurring plant phenols, Cancer Research, 47, pp. 760-766, (1987)
[5]  
Gaydou E.M., Bianchini J.-P., Randriamiharisoa R.P., Orange and mandarin peel oils differentiation using polymethoxylated flavone composition, Journal of Agriculture and Food Chemistry, 35, pp. 525-529, (1987)
[6]  
Guengerich F.P., Kim D.-H., In vitro inhibition of dihydropyridine oxidation and AFB<sub>1</sub> activation in human liver microsomes by naringenin and other flavonoids, Carcinogenesis, 11, pp. 2275-2279, (1990)
[7]  
Guengerich F.P., Martin M.V., Beune P.H., Kremers P., Wolff T., Waxman D.J., Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism, Journal of Biological Chemistry, 261, pp. 5051-5060, (1986)
[8]  
Hertog M.G.L., Hollman P.C.H., Van de Putte B., Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices, Journal of Agriculture and Food Chemistry, 412, pp. 1242-1246, (1993)
[9]  
Huang M.T., Chang R.L., Fortner J.G., Conney A.H., Studies on the mechanism of activation of microsomal benzo(a)pyrene hydroxylation by flavonoids, Journal of Biological Chemistry, 256, pp. 6829-6836, (1981)
[10]  
Kapitulnik J., Poppers P.J., Buening M.K., Fortner J.G., Conney A.H., Activation of monooxygenases in human liver by 7,8-benzoflavone, Clinical Pharmacy and Therapeutics, 22, pp. 475-484, (1977)